Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics - Archive ouverte HAL Access content directly
Journal Articles Exploration of Targeted Anti-tumor Therapy Year : 2022

Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics

Abstract

During the past two decades, tremendous progress has been made in the dendrimer-based delivery of therapeutic molecules including, for instance, small molecules, macromolecules, and genes. This review deals with recent successes in the development of promising biocompatible phosphorus dendrimers, a specific type of dendrimer, to deliver genes to treat cancers.
Fichier principal
Vignette du fichier
Mignani, Engineered phosphorus dendrimers, 2022.pdf (1.88 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-03659099 , version 1 (04-05-2022)

Licence

Identifiers

Cite

Serge Mignani, Xiangyang Shi, Maria Bryszewska, Dzmitry Shcharbin, Jean-Pierre Majoral. Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics. Exploration of Targeted Anti-tumor Therapy, 2022, 3 (1), pp.50-61. ⟨10.37349/etat.2022.00071⟩. ⟨hal-03659099⟩
47 View
63 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More